CIK 0001042418 · Non-accelerated filer<br>Smaller reporting company
Inhibitor Therapeutics, Inc.
Sign in to watch- Ticker
- INTI
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 541641133
- Phone
- (813) 766-2462
- Business address
- 4830 W. KENNEDY BLVD., SUITE 600, TAMPA, FL, 33609
- Former names
- HedgePath Pharmaceuticals, Inc., COMMONWEALTH BIOTECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 78 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-05 | MCNULTY JAMES A See Remarks | Other acquisition | +20,101,057 | 26,101,057 | ||
| 2023-05-05 | Yanez Michelle Director | Other acquisition | +796,271 | 800,673 | ||
| 2021-01-15 | Mayne Pharma Ventures Pty Ltd 10% owner | Other acquisition | +2,240,488 | 204,083,227 | ||
| 2020-12-22 | Hasara Garrison J. CFO and Treasurer | Grant or award · Common Stock Option | +125,000 | 125,000 | ||
| 2020-12-22 | Watson W. Mark Director | Grant or award · Common Stock Option | +1,306,452 | 1,306,452 | ||
| 2020-12-22 | Ono Richard Dana Director | Grant or award · Common Stock Option | +754,839 | 754,839 | ||
| 2020-12-22 | Peattie Debra Director | Grant or award · Common Stock Option | +580,646 | 580,646 | ||
| 2020-12-22 | VIRCA NICHOLAS J President and CEO | Grant or award · Common Stock Option | +125,000 | 125,000 | ||
| 2020-12-22 | Martin Robert Daniel Director | Grant or award · Common Stock Option | +754,839 | 754,839 | ||
| 2020-09-17 | VIRCA NICHOLAS J President and CEO | Grant or award · Common Stock Option | +100,000 | 100,000 | ||
| 2020-09-17 | Hasara Garrison J. CFO and Treasurer | Grant or award · Common Stock Option | +100,000 | 100,000 | ||
| 2020-07-15 | Mayne Pharma Ventures Pty Ltd 10% owner | Other acquisition | +3,189,688 | 201,842,739 | ||
| 2020-03-20 | Ono Richard Dana Director | Grant or award · Common Stock Option | +1,000,000 | 1,000,000 | ||
| 2020-03-20 | Peattie Debra Director | Grant or award · Common Stock Option | +1,000,000 | 1,000,000 | ||
| 2020-03-20 | Martin Robert Daniel Director | Grant or award · Common Stock Option | +1,000,000 | 1,000,000 | ||
| 2020-03-20 | Watson W. Mark Director | Grant or award · Common Stock Option | +1,500,000 | 1,500,000 | ||
| 2019-12-12 | Peattie Debra Director | Grant or award · Common Stock Option | +210,000 | 210,000 | ||
| 2019-12-02 | Hasara Garrison J. CFO and Treasurer | Purchase | +13,500 | $0.07 | $945 | 3,972,544 |
| 2019-06-03 | Watson W. Mark Director | Grant or award · Common Stock Option | +25,000 | 25,000 | ||
| 2019-02-03 | Ono Richard Dana Director | Grant or award · Common Stock Option | +657,895 | 657,895 |
Page 2 of 9 · 165 trades